Tokyo, August 2 , 2024 – Genesis Healthcare will be present at Bio Japan 2024 in Yokohama from October 9th to 11th.
Visit our teams at booth D-75 to learn about our latest developments and genomic services, including GenesisGaia, GenesisPro, and GeneLife.
Additionally, GenesisGaia will host a seminar on October 10th at 11:30 am, focusing on harnessing genomic data and A.I. to advance R&D and drug discovery. Our speakers include Michel Mommejat, our Chief Innovation Officer, and Yoshisuke Yamada, Board Member and Chief Legal Officer.
More information about Bio Japan here.
For press and media inquiries, please contact:
Email: press@genesis-healthcare.jp
About Genesis Healthcare Co.
Celebrating its 20th anniversary, Genesis Healthcare Co. is Japan’s leading genetic testing and research company, servicing medical institutions, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented A.I. driven prediction models, Genesis Healthcare Co. provides advanced genetic testing services, from prevention to diagnostics.
For additional information, please visit:
GenesisGaia, GenesisPro and GeneLife are registered trademarks of Genesis Healthcare Co.
Opmerkingen